Literature DB >> 20124887

Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality.

Geert Meyfroidt1, Daniel M Keenan, Xin Wang, Pieter J Wouters, Johannes D Veldhuis, Greet Van den Berghe.   

Abstract

OBJECTIVES: To assess the effect of intensive insulin therapy on blood glucose amplitude variation and pattern irregularity in critically ill patients. To assess the association of these blood glucose signal characteristics with hospital mortality, independent of blood glucose level.
DESIGN: Retrospective analysis of the databases of two previously published randomized controlled trials.
SETTING: University hospital, 56-bed adult surgical intensive care unit and 17-bed medical intensive care unit. PATIENTS: One thousand five-hundred forty-eight surgical intensive care unit patients, admitted between February 2000 and January 2001, and 1200 medical intensive care unit patients, admitted between March 2002 and May 2005.
INTERVENTIONS: In the two randomized controlled trials, patients were randomized to receive either intensive insulin therapy (targeting normoglycemia, between 4.4 and 6.1 mmol/L) or conventional insulin therapy (infusing insulin when blood glucose levels were >12 mmol/L and stopping at 10 mmol/L).
MEASUREMENTS AND MAIN RESULTS: Intensive insulin therapy significantly lowered mean blood glucose (5.8 vs. 8.4 mmol/L), hyperglycemic index (0.8 vs. 3.2 mmol/L), and glycemic penalty index (26 vs. 53), but it increased the mean daily difference between minimum and maximum blood glucose (mean daily delta blood glucose; 4.0 vs. 3.3 mmol/L). There was no significant effect on the standard deviation of the blood glucose measurements or on jack-knifed approximate entropy. In multivariable logistic regression analysis, corrected for baseline risk factors, blood glucose levels outside the normoglycemic range, higher mean daily delta blood glucose, higher standard deviation blood glucose, and higher jack-knifed approximate entropy were independently associated with hospital mortality.
CONCLUSIONS: The Leuven intensive insulin therapy strategy increased mean daily delta blood glucose while not affecting standard deviation blood glucose and jack-knifed approximate entropy. Increased blood glucose amplitude variation and pattern irregularity were associated with mortality, irrespective of blood glucose level. The reduced mortality observed with intensive insulin therapy in the Leuven trials cannot be attributed to an effect on blood glucose amplitude variation or entropy. Reducing amplitude variation and entropy of the blood glucose signal, irrespective of blood glucose concentration, may produce clinical benefits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124887     DOI: 10.1097/CCM.0b013e3181cf710e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  60 in total

1.  The metrics of glycaemic control in critical care.

Authors:  Iain M J Mackenzie; Tony Whitehouse; Peter G Nightingale
Journal:  Intensive Care Med       Date:  2011-01-06       Impact factor: 17.440

2.  Understanding glycemic control in the critically ill: three domains are better than one.

Authors:  James S Krinsley
Journal:  Intensive Care Med       Date:  2011-01-06       Impact factor: 17.440

3.  Multiplicative surrogate standard deviation: a group metric for the glycemic variability of individual hospitalized patients.

Authors:  Susan S Braithwaite; Guillermo E Umpierrez; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

4.  The impact of measurement frequency on the domains of glycemic control in the critically ill--a Monte Carlo simulation.

Authors:  James S Krinsley; David E Bruns; James C Boyd
Journal:  J Diabetes Sci Technol       Date:  2015-01-06

Review 5.  Management of critically ill patients with type 2 diabetes: The need for personalised therapy.

Authors:  Palash Kar; Karen L Jones; Michael Horowitz; Adam M Deane
Journal:  World J Diabetes       Date:  2015-06-10

Review 6.  Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

Review 7.  Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!

Authors:  Paul E Marik
Journal:  Intensive Care Med       Date:  2016-05-09       Impact factor: 17.440

8.  Postoperative Hypoglycemia Is Associated With Worse Outcomes After Cardiac Operations.

Authors:  Lily E Johnston; Jennifer L Kirby; Emily A Downs; Damien J LaPar; Ravi K Ghanta; Gorav Ailawadi; Benjamin D Kozower; Irving L Kron; Anthony L McCall; James M Isbell
Journal:  Ann Thorac Surg       Date:  2016-08-25       Impact factor: 4.330

9.  Risk factors for hypoglycaemia in neurocritical care patients.

Authors:  Freya M van Iersel; Arjen J C Slooter; Renee Vroegop; Annemiek E Wolters; Charlotte A M Tiemessen; Rik H J Rösken; Johannes G van der Hoeven; Linda M Peelen; Cornelia W E Hoedemaekers
Journal:  Intensive Care Med       Date:  2012-08-21       Impact factor: 17.440

Review 10.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.